Gershenson DM

No ORCID on file · 9 papers in corpus · active 1987-2018

Study types

  • article 5
  • other 1

Condition tags

  • endometriosis 4
  • adenomyosis 1
2018
Gynecologic Oncology ·doi:10.1016/j.ygyno.2018.05.029

ObjectivesTo determine the efficacy and tolerability of sunitinib in recurrent or persistent clear cell ovarian cancer patients.MethodsAll patients had one or two prior regimens with measurable disease. Tumors were at least 50% clear cell h…

2017
Gynecologic Oncology ·doi:10.1016/j.ygyno.2017.08.004

PurposeWe examined disparities in prognosis between patients with ovarian clear cell carcinoma (OCCC) and serous epithelial ovarian cancer (SOC).MethodsWe reviewed data from FIGO stage I-IV epithelial ovarian cancer patients who participate…

2015
PloS one ·doi:10.1371/journal.pone.0135101

Epithelial ovarian cancer is a diverse molecular and clinical disease, yet standard treatment is the same for all subtypes. TP53 mutations represent a node of divergence in epithelial ovarian cancer histologic subtypes and may represent a t…

other 2015
Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·doi:10.1200/JCO.2014.58.3401

PURPOSE: The phosphoinositol-3 kinase (PI3K) pathway is frequently dysregulated in endometrial cancer (EC). Hormonal manipulation leads to response in some patients with EC, but resistance derived from PI3K pathway activation has been docum…

article 2002
Obstetrics and gynecology ·doi:10.1016/s0029-7844(02)02149-x

OBJECTIVE: To determine clinical characteristics of women with endometriosis-associated intraperitoneal cancers, to assess differences based on the relationship of the cancer to the endometriosis, and to assess factors associated with survi…

article 1990
Gynecologic oncology ·doi:10.1016/0090-8258(90)90263-k

From 1967 through December 1987, 145 patients with endometrioid carcinoma of the ovary were treated at the University of Texas M. D. Anderson Cancer Center. Thirty-eight patients (26.2%) had stage I disease, 28 (19.3%) stage II, 60 (41.4%) …

article 1989
Gynecologic oncology ·doi:10.1016/0090-8258(89)90043-7

Clear cell carcinoma of the ovary accounts for 2 to 3% of all epithelial ovarian neoplasms. Patient profiles, pathological characteristics, and results of treatment are reviewed for 59 patients. The median age was 51. Disease extent at diag…

article 1989
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists ·doi:10.1097/00004347-198906000-00007

The presence of endometrial tissue in myometrial vessels has been described in the literature primarily in association with the menstrual period. We reviewed 277 hysterectomy specimens to assess the frequency of endometrial tissue in myomet…

article 1987
Archives of pathology & laboratory medicine

A 45-year-old woman developed a grade III and stage III squamous cell carcinoma of the left ovary 12 years after a hysterectomy for treatment of endometriosis. Origin from a teratoma or a Brenner tumor was excluded. Despite extensive surger…